Sexton Biotechnologies
Indianapolis, US · Founded 2019 · Delaware corporation · 2 known investors
Founders & leadership
DD
Doug DayhoffNamed on SEC filing
SW
Sean WernerNamed on SEC filing
BK
Brad KingNamed on SEC filing
Board
EC
Eli CasdinBoard director
MR
Mike RiceBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2019
▶$5MraisedOct 2019 · 4 investors · BiotechnologyRule 506(b)
▶$5MraisedOct 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Doug DayhoffDirector
- Sean WernerExecutive Officer, Director
- Eli CasdinDirector
- Brad KingDirector
- Mike RiceDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $500K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Sexton Biotechnologies's investors?
- Sexton Biotechnologies's investors include BioCrossroads, Casdin Capital.
- How much funding has Sexton Biotechnologies raised?
- Sexton Biotechnologies has disclosed $5M raised across 1 round.
- Where is Sexton Biotechnologies headquartered?
- Sexton Biotechnologies is headquartered in Indianapolis, US.